Dr Philippe Pouletty, MD – Co-Founder and General Partner, Life Sciences
Dr Philippe Pouletty: MD – Co-Founder and General Partner, Life Sciences
- Biotech industry veteran with a dual experience in Silicon Valley and in France
- Founder of three biotechnology companies: SangStat, Conjuchem, and DrugAbuse. Two of them have gone public: SangSat in 1993 (Nasdaq: SANG) and Conjuchem in 2000 (Toronto Stock Exchange: CJB)
- Chairman of France Biotech, the French Industry Association
- Former Vice-Chairman of Europabio, the European Biotech Industry Association
- Owner of 29 patents
- Board member of Neovacs, BMD, Cytomics, Vexim, Wittycell, Symetis (Switzerland), Theraclion, Deinove
- Independent board member of Conjuchem (quote symbol) and Innate
Pharma - « Chevalier de la Légion d’Honneur »
- MD from University of Paris VI, immunology, laureate from Pasteur Institute. Post-doctoral research fellow at Stanford University and 1999 laureate of the American Liver Foundation
- Member of the “Conseil Stratégique pour l’Attractivité de la France”, chaired by the French prime minister